Ekaterina Bogdanov
Image of Ekaterina Bogdanov

Ekaterina Bogdanov

Associate

Ekaterina represents investment banks and corporate issuers in a broad range of public and private capital markets transactions, as well as provides ongoing corporate advice.
Ekaterina's practice includes initial public offerings, follow-on, secondary and other equity offerings, acquisition financings, investment grade and high-yield debt issuances, cross-border securities offerings and liability management transactions in a wide range of industries, including life sciences, media and telecommunications, financial services, metals and mining, and sovereign issuers.

Expertise

Experience

Representative matters

Going Public Transactions
  • BofA Securities and a global financial institution as representatives of the underwriters in connection with the upsized $180 million initial public offering of CeriBell, Inc.
  • A multinational telecommunications company on the $3.2 billion initial market capitalization spin-off and dual SIX and Nasdaq listing of its Swiss telecommunications business, Sunrise Communications AG.
  • BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse and a global financial institution as joint book-running managers in connection with the upsized $221 million initial public offering of Mineralys Therapeutics, Inc.
  • TELUS International (Cda) Inc. in its upsized $1.06 billion initial public offering and NYSE listing
  • BofA Securities and William Blair as lead bookrunning managers and LifeSci Capital as co-manager in $176 million initial public offering of Lucira Health, Inc.
  • Genmab in its $506 million initial public offering and listing of American Depositary Shares on the Nasdaq.
  • Sundial Growers in its $143 million initial public offering and listing of common shares on the Nasdaq.
Follow-on and Other Equity Offerings
  • BofA Securities, Evercore and Goldman Sachs as representatives of the underwriters in connection a $175 million follow-on public equity offering by Mineralys Therapeutics, Inc.
  • TD Securities and Goldman Sachs as representatives of the underwriters in connection with a $13.1 billion secondary registered offering of shares of The Charles Schwab Corporation by The Toronto-Dominion Bank. The transaction marked the largest financial services public equity offering of the past five years and one of the largest equity offerings in the United States in a decade. Through the equity offering and a $1.5 billion repurchase by Charles Schwab of its shares from TD Bank, TD Bank sold its entire 10.1% economic stake in Charles Schwab for a total of $14.6 billion in gross proceeds.
  • BofA Securities and J.P. Morgan as joint underwriters and bookrunning managers in connection with the $404 million follow-on public equity offering by Bruker Corporation
  • BofA Securities, Piper Sandler and Morgan Stanley as joint book-running managers in connection with $175 million follow-on public equity offering by PROCEPT BioRobotics® Corporation
  • BofA Securities and the other underwriters in Exact Sciences Corporation’s (i) public offering of $747.5 million aggregate principal amount of its 0.3750% convertible senior notes due 2027 and (ii) concurrent exchange of approximately $493.4 million of its outstanding principal amount of 1.0% convertible senior notes due 2025 for cash and shares
Debt Offerings
  • Genmab A/S in connection with its $1.5 billion senior secured notes offering and $1 billion senior unsecured notes offering to finance its acquisition of Merus N.V.
  • A healthcare company in connection with its $6 billion and $5 billion senior note offerings to finance a healthcare company's $10.6 billion acquisition of Oak Street Health, Inc.
  • Vitality Re XV Limited, a healthcare company, Aetna Life Insurance Company and Health Re, Inc. in connection with Vitality Re XV Limited’s $140 million Series 2024, Class A Principal-at-Risk Variable Rate Notes and $60 million Series 2024, Class B Principal-at-Risk Variable Rate Notes.
  • The Bank of Nova Scotia, the Province of Ontario and the Province of British Columbia in connection with their registered debt offerings.
  • BofA Securities, Barclays, BMO and other underwriters in connection with Bell Canada’s registered debt offerings.
  • BofA Securities, Inc., BMO Capital Markets Corp., a global financial institution and RBC Capital Markets, LLC as joint bookrunners in connection with a $1.25 billion notes offering by Kinder Morgan, Inc.
  • J.P. Morgan, Morgan Stanley, BofA Securities, and a global financial institution as underwriters in connection with a $600 million notes offering by Steel Dynamics, Inc.
  • Mizuho Securities USA LLC, A Japanese asset manager, Inc., TD Securities (USA) LLC and a global financial institution, LLC as joint bookrunners in connection with a $2.25 billion notes offering by Kinder Morgan, Inc.
  • Mizuho, TD Securities and US Bancorp as joint book-running managers in connection with a $800 million notes offering by Atmos Energy Corporation.
  • Barclays, Mizuho, TD Securities, and a global financial institution, in connection with a $750 shelf takedown of notes by ONEOK Inc.
  • J.P. Morgan Securities and other managers in connection with a $550 million private placement of notes by Teck Resources Limited.

Published Work

  • Mujalovic, I., Halbhuber, H. & Bogdanov, E. (2024) “Initial Public Offerings, 2024”, Chapter “Going public in the USA: an overview of the regulatory framework and capital markets process for IPOs.” Global Legal Insights.
  • Masella, R., Mujalovic, I. & Bogdanov, E. (2022) “Health Care Mergers and Acquisitions Answer Book”, Chapter 11. Financing Drug Development Actions, Practising Law Institute

Qualifications

Admissions

Attorney-at-Law, New York

Foreign Legal Consultant, Province of Ontario, Canada, 2026

Academic

MBA, with distinction, BBA with distinction, Schulich School of Business

J.D., Osgoode Hall Law School York University

Languages

Russian
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.